• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高致病性人冠状病毒感染期间的肝损伤。

Liver injury during highly pathogenic human coronavirus infections.

机构信息

Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Liver Int. 2020 May;40(5):998-1004. doi: 10.1111/liv.14435. Epub 2020 Mar 30.

DOI:10.1111/liv.14435
PMID:32170806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7228361/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), the pathogen of 2019 novel coronavirus disease (COVID-19), has posed a serious threat to global public health. The WHO has declared the outbreak of SARS-CoV-2 infection an international public health emergency. Lung lesions have been considered as the major damage caused by SARS-CoV-2 infection. However, liver injury has also been reported to occur during the course of the disease in severe cases. Similarly, previous studies have shown that liver damage was common in the patients infected by the other two highly pathogenic coronavirus - severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), and associated with the severity of diseases. In this review, the characteristics and mechanism of liver injury caused by SARS-CoV, MERS-CoV as well as SARS-CoV-2 infection were summarized, which may provide help for further studies on the liver injury of COVID-19.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是 2019 年新型冠状病毒病(COVID-19)的病原体,对全球公共卫生构成了严重威胁。世界卫生组织已宣布 SARS-CoV-2 感染爆发为国际公共卫生紧急事件。肺部病变被认为是 SARS-CoV-2 感染引起的主要损伤。然而,在严重病例中,也有报道称在疾病过程中会发生肝损伤。同样,先前的研究表明,感染另外两种高致病性冠状病毒——严重急性呼吸综合征冠状病毒(SARS-CoV)和中东呼吸综合征冠状病毒(MERS-CoV)的患者中也常发生肝损伤,且与疾病的严重程度相关。在这篇综述中,总结了 SARS-CoV、MERS-CoV 以及 SARS-CoV-2 感染引起肝损伤的特征和机制,这可能有助于进一步研究 COVID-19 的肝损伤。

相似文献

1
Liver injury during highly pathogenic human coronavirus infections.高致病性人冠状病毒感染期间的肝损伤。
Liver Int. 2020 May;40(5):998-1004. doi: 10.1111/liv.14435. Epub 2020 Mar 30.
2
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.新兴人类致病冠状病毒 SARS-CoV、MERS-CoV 和 2019-nCoV 的病理学和发病机制的重叠和离散方面。
J Med Virol. 2020 May;92(5):491-494. doi: 10.1002/jmv.25709. Epub 2020 Feb 21.
3
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.SARS-CoV、MERS-CoV 和 SARS-CoV-2 感染中的免疫致病反应和血液病理效应的重点。
Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020.
4
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.新型冠状病毒表现的全面综述——在致命的 COVID-19 全球大流行背景下。
Am J Med Sci. 2020 Jul;360(1):5-34. doi: 10.1016/j.amjms.2020.05.006. Epub 2020 May 11.
5
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.SARS-CoV、MERS-CoV 和 SARS-CoV-2 冠状病毒感染的比较免疫学特征。
Front Immunol. 2020 Aug 14;11:2033. doi: 10.3389/fimmu.2020.02033. eCollection 2020.
6
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2),一种新出现的病原体:概述。
Pathog Dis. 2020 Aug 1;78(6). doi: 10.1093/femspd/ftaa042.
7
Coronavirus Disease 2019: Coronaviruses and Blood Safety.2019 年冠状病毒病:冠状病毒与血液安全。
Transfus Med Rev. 2020 Apr;34(2):75-80. doi: 10.1016/j.tmrv.2020.02.003. Epub 2020 Feb 21.
8
A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection.与 SARS-CoV-2 感染相关的胎盘形态和组织病理学病变的系统评价。
Placenta. 2020 Nov;101:13-29. doi: 10.1016/j.placenta.2020.08.018. Epub 2020 Aug 23.
9
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.新冠病毒、中东呼吸综合征病毒和严重急性呼吸综合征病毒在非人灵长类动物模型中的比较发病机制。
Science. 2020 May 29;368(6494):1012-1015. doi: 10.1126/science.abb7314. Epub 2020 Apr 17.
10
[Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].甲型H1N1流感病毒、高致病性H5N1禽流感病毒、严重急性呼吸综合征冠状病毒、中东呼吸综合征冠状病毒及2019新型冠状病毒所致病理变化与致病机制比较
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):511-516. doi: 10.3760/cma.j.cn112151-20200301-00155.

引用本文的文献

1
Bacterial infections and pathogenic situations: The case of .细菌感染与致病情况:以……为例
Virulence. 2025 Dec;16(1):2543538. doi: 10.1080/21505594.2025.2543538. Epub 2025 Aug 13.
2
The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative.2019年冠状病毒病(COVID-19)及COVID-19疫苗接种对临床试验期间疑似急性药物性肝损伤的检测、评估及管理的影响:IQ药物性肝损伤倡议组织的共识建议
Drug Saf. 2025 Aug 5. doi: 10.1007/s40264-025-01591-0.
3
Three-Year Follow-Up of COVID-19 Cases in District of Constance, Germany. A Prospective, Controlled Cohort Study (FSC19-KN).德国康斯坦茨地区新冠肺炎病例的三年随访。一项前瞻性对照队列研究(FSC19-KN)。
J Clin Med. 2025 Feb 21;14(5):1439. doi: 10.3390/jcm14051439.
4
Assessment of serum biomarker changes following the COVID-19 pandemic and vaccination: a cohort study in Sylhet, Bangladesh.评估新冠疫情和疫苗接种后血清生物标志物的变化:孟加拉国锡尔赫特的一项队列研究
Front Public Health. 2025 Feb 21;13:1435930. doi: 10.3389/fpubh.2025.1435930. eCollection 2025.
5
Assessing the impact of COmorbidities and Sociodemographic factors on Multiorgan Injury following COVID-19: rationale and protocol design of COSMIC, a UK multicentre observational study of COVID-negative controls.评估合并症和社会人口学因素对COVID-19后多器官损伤的影响:COSMIC的原理和方案设计,一项关于COVID阴性对照的英国多中心观察性研究。
BMJ Open. 2025 Mar 6;15(3):e089508. doi: 10.1136/bmjopen-2024-089508.
6
Hepatitis B virus associated with severe acute respiratory syndrome coronavirus 2 infection: a case report.与严重急性呼吸综合征冠状病毒2感染相关的乙型肝炎病毒:一例报告。
J Med Case Rep. 2025 Feb 27;19(1):80. doi: 10.1186/s13256-025-05085-6.
7
Angiotensin-converting enzyme 2 and hepatic SARS-CoV-2 infection: Regulation, association, and therapeutic implications.血管紧张素转换酶2与肝脏严重急性呼吸综合征冠状病毒2感染:调控、关联及治疗意义
World J Gastroenterol. 2025 Feb 14;31(6):100864. doi: 10.3748/wjg.v31.i6.100864.
8
SARS-CoV-2 Productively Infects Human Hepatocytes and Induces Cell Death.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)可有效感染人肝细胞并诱导细胞死亡。
J Med Virol. 2025 Jan;97(1):e70156. doi: 10.1002/jmv.70156.
9
Impact of chronic ethanol consumption and SARS-COV-2 on the liver and intestine: A pilot dose-response study in mice.慢性乙醇摄入与SARS-CoV-2对肝脏和肠道的影响:一项小鼠剂量反应初步研究
Alcohol Clin Exp Res (Hoboken). 2025 Mar;49(3):587-598. doi: 10.1111/acer.15528. Epub 2025 Jan 5.
10
Clinical characteristics of coronavirus disease 2019 patients with hepatitis B virus super-infection.2019冠状病毒病合并乙型肝炎病毒重叠感染患者的临床特征
Rev Inst Med Trop Sao Paulo. 2024 Dec 16;66:e74. doi: 10.1590/S1678-9946202466074. eCollection 2024.

本文引用的文献

1
Clinical characteristics of 82 cases of death from COVID-19.COVID-19 死亡 82 例的临床特征。
PLoS One. 2020 Jul 9;15(7):e0235458. doi: 10.1371/journal.pone.0235458. eCollection 2020.
2
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.SARS-CoV-2 感染患者外周血淋巴细胞反应和细胞因子谱的纵向特征。
EBioMedicine. 2020 May;55:102763. doi: 10.1016/j.ebiom.2020.102763. Epub 2020 Apr 18.
3
Clinical Features of COVID-19-Related Liver Functional Abnormality.新型冠状病毒病相关肝功能异常的临床特征。
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1561-1566. doi: 10.1016/j.cgh.2020.04.002. Epub 2020 Apr 10.
4
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China.中国湖北省外指定传染病医院的 COVID-19 疫情。
Allergy. 2020 Jul;75(7):1742-1752. doi: 10.1111/all.14309. Epub 2020 Apr 17.
5
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.中国武汉 81 例新冠肺炎患者的放射学特征:一项描述性研究。
Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.
6
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
7
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
8
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.一组在中国武汉以外地区感染 2019 年新型冠状病毒(SARS-CoV-2)的患者的临床特征:回顾性病例系列。
BMJ. 2020 Feb 19;368:m606. doi: 10.1136/bmj.m606.
9
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
10
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.